Renin-angiotensin

Amy C. Arnold; Debra I. Diz

doi:10.1016/B978-0-323-85492-4.00082-X

Renin-angiotensin

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The renin-angiotensin system (RAS) is a widely recognized regulator of cardiovascular control, under both physiological and pathophysiological conditions. Pharmacological therapies targeting this hormonal system are used routinely for treatment of hypertension and cardiovascular disease. Accumulating evidence supports involvement of the autonomic nervous system (ANS) in the cardiovascular effects of the RAS, and vice versa, with angiotensin peptides influencing both sympathetic and parasympathetic activity via receptors localized to the brain, spinal cord, ganglia, and vasculature. This chapter highlights clinical and experimental evidence for ANS-RAS interactions integral to normal cardiovascular control and to pathophysiology.

Original language	English (US)
Title of host publication	Primer on the Autonomic Nervous System, Fourth Edition
Publisher	Elsevier
Pages	113-118
Number of pages	6
ISBN (Electronic)	9780323854924
ISBN (Print)	9780323854931
DOIs	https://doi.org/10.1016/B978-0-323-85492-4.00082-X
State	Published - Jan 1 2022

All Science Journal Classification (ASJC) codes

General Medicine
General Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-323-85492-4.00082-X

Cite this

@inbook{4b228d3f6be848f2b70f3dd95e0c9c5f,

title = "Renin-angiotensin",

abstract = "The renin-angiotensin system (RAS) is a widely recognized regulator of cardiovascular control, under both physiological and pathophysiological conditions. Pharmacological therapies targeting this hormonal system are used routinely for treatment of hypertension and cardiovascular disease. Accumulating evidence supports involvement of the autonomic nervous system (ANS) in the cardiovascular effects of the RAS, and vice versa, with angiotensin peptides influencing both sympathetic and parasympathetic activity via receptors localized to the brain, spinal cord, ganglia, and vasculature. This chapter highlights clinical and experimental evidence for ANS-RAS interactions integral to normal cardiovascular control and to pathophysiology.",

author = "Arnold, {Amy C.} and Diz, {Debra I.}",

year = "2022",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-85492-4.00082-X",

language = "English (US)",

isbn = "9780323854931",

pages = "113--118",

booktitle = "Primer on the Autonomic Nervous System, Fourth Edition",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Renin-angiotensin

AU - Arnold, Amy C.

AU - Diz, Debra I.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - The renin-angiotensin system (RAS) is a widely recognized regulator of cardiovascular control, under both physiological and pathophysiological conditions. Pharmacological therapies targeting this hormonal system are used routinely for treatment of hypertension and cardiovascular disease. Accumulating evidence supports involvement of the autonomic nervous system (ANS) in the cardiovascular effects of the RAS, and vice versa, with angiotensin peptides influencing both sympathetic and parasympathetic activity via receptors localized to the brain, spinal cord, ganglia, and vasculature. This chapter highlights clinical and experimental evidence for ANS-RAS interactions integral to normal cardiovascular control and to pathophysiology.

AB - The renin-angiotensin system (RAS) is a widely recognized regulator of cardiovascular control, under both physiological and pathophysiological conditions. Pharmacological therapies targeting this hormonal system are used routinely for treatment of hypertension and cardiovascular disease. Accumulating evidence supports involvement of the autonomic nervous system (ANS) in the cardiovascular effects of the RAS, and vice versa, with angiotensin peptides influencing both sympathetic and parasympathetic activity via receptors localized to the brain, spinal cord, ganglia, and vasculature. This chapter highlights clinical and experimental evidence for ANS-RAS interactions integral to normal cardiovascular control and to pathophysiology.

UR - http://www.scopus.com/inward/record.url?scp=85150105763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150105763&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-85492-4.00082-X

DO - 10.1016/B978-0-323-85492-4.00082-X

M3 - Chapter

AN - SCOPUS:85150105763

SN - 9780323854931

SP - 113

EP - 118

BT - Primer on the Autonomic Nervous System, Fourth Edition

PB - Elsevier

ER -

Renin-angiotensin

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this